KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT • US50101L1061

3 USD
+0.08 (+2.74%)
At close: Feb 18, 2026
3.04 USD
+0.04 (+1.33%)
After Hours: 2/18/2026, 6:11:53 PM
Fundamental Rating

1

DNUT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 126 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of DNUT have multiple concerns. DNUT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DNUT has reported negative net income.
  • DNUT had a positive operating cash flow in the past year.
  • In the past 5 years DNUT reported 4 times negative net income.
  • Each year in the past 5 years DNUT had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • DNUT's Return On Assets of -19.63% is on the low side compared to the rest of the industry. DNUT is outperformed by 92.86% of its industry peers.
  • The Return On Equity of DNUT (-76.15%) is worse than 70.63% of its industry peers.
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

  • The Gross Margin of DNUT (28.67%) is worse than 78.57% of its industry peers.
  • In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
  • DNUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

0

2. Health

2.1 Basic Checks

  • DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DNUT has more shares outstanding
  • The number of shares outstanding for DNUT has been increased compared to 5 years ago.
  • DNUT has a worse debt/assets ratio than last year.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.11, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of DNUT (0.11) is worse than 84.92% of its industry peers.
  • A Debt/Equity ratio of 1.35 is on the high side and indicates that DNUT has dependencies on debt financing.
  • DNUT has a Debt to Equity ratio (1.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 0.11
ROIC/WACCN/A
WACC7.06%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • DNUT has a Current Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DNUT has a worse Current ratio (0.36) than 88.10% of its industry peers.
  • DNUT has a Quick Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.30, DNUT is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

  • DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -190.00%.
  • DNUT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.40%.
  • DNUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.
EPS 1Y (TTM)-190%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-10.4%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-1.2%

3.2 Future

  • DNUT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.87% yearly.
  • Based on estimates for the next years, DNUT will show a small growth in Revenue. The Revenue will grow by 3.64% on average per year.
EPS Next Y-266.03%
EPS Next 2Y-67%
EPS Next 3Y-29.89%
EPS Next 5Y-14.87%
Revenue Next Year-9.13%
Revenue Next 2Y-5.79%
Revenue Next 3Y-1.85%
Revenue Next 5Y3.64%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2030 0 0.2 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

  • DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DNUT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

  • 69.05% of the companies in the same industry are cheaper than DNUT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.59
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • DNUT's earnings are expected to decrease with -29.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67%
EPS Next 3Y-29.89%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.68%, DNUT is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.10, DNUT pays a better dividend. On top of this DNUT pays more dividend than 94.44% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, DNUT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.68%

5.2 History

  • DNUT has been paying a dividend for over 5 years, so it has already some track record.
  • DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.5%
EPS Next 2Y-67%
EPS Next 3Y-29.89%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

KRISPY KREME INC

NASDAQ:DNUT (2/18/2026, 6:11:53 PM)

After market: 3.04 +0.04 (+1.33%)

3

+0.08 (+2.74%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners43.74%
Inst Owner Change1.04%
Ins Owners3.64%
Ins Owner Change0.06%
Market Cap513.90M
Revenue(TTM)1.53B
Net Income(TTM)-510.43M
Analysts52.31
Price Target4.43 (47.67%)
Short Float %28.53%
Short Ratio9.17
Dividend
Industry RankSector Rank
Dividend Yield 4.68%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-3.5%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-117.45%
Min EPS beat(2)-353.46%
Max EPS beat(2)118.57%
EPS beat(4)1
Avg EPS beat(4)-81.52%
Min EPS beat(4)-353.46%
Max EPS beat(4)118.57%
EPS beat(8)2
Avg EPS beat(8)-67.78%
EPS beat(12)5
Avg EPS beat(12)-46.53%
EPS beat(16)6
Avg EPS beat(16)-38.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.39%
PT rev (1m)1.46%
PT rev (3m)3.74%
EPS NQ rev (1m)-30.6%
EPS NQ rev (3m)530.56%
EPS NY rev (1m)-1.73%
EPS NY rev (3m)18.61%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF 32.22
P/B 0.77
P/tB N/A
EV/EBITDA 19.59
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.09
OCFY3.1%
SpS8.96
BVpS3.91
TBVpS-4.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.67%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 12.25
Cap/Depr 83.67%
Cap/Sales 7.48%
Interest Coverage N/A
Cash Conversion 21.56%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.11
F-Score5
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-190%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-266.03%
EPS Next 2Y-67%
EPS Next 3Y-29.89%
EPS Next 5Y-14.87%
Revenue 1Y (TTM)-10.4%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-1.2%
Revenue Next Year-9.13%
Revenue Next 2Y-5.79%
Revenue Next 3Y-1.85%
Revenue Next 5Y3.64%
EBIT growth 1Y-1143.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year505.97%
EBIT Next 3Y89.74%
EBIT Next 5Y57.43%
FCF growth 1Y-709.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.9%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%

KRISPY KREME INC / DNUT FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


Can you provide the valuation status for KRISPY KREME INC?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


Can you provide the profitability details for KRISPY KREME INC?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for KRISPY KREME INC?

The Earnings per Share (EPS) of KRISPY KREME INC (DNUT) is expected to decline by -266.03% in the next year.